Columbia Care and Moeller Pharma GmbH Enter into Exclusive Agreement to Develop Portfolio of Proprietary, Plant-Based Combination Cannabinoid Functional Health and Wellness Products
Columbia Care Announces Collaboration with IPS Specials and Grow Biotech to Import BeneCeed™ Tablets to the United Kingdom for Clinical Study
Cowen Cannabis Executive Summit
Eight Capital: Global Cannabis Conference
Fall Investor Summit
Beacon Securities Conference
Receive updates straight into your inboxSign up today
Licenses in 15 jurisdictions across
U.S. and E.U.
(includes industrial hemp cultivation)
Facilities that are operational or in development.
Sales transactions to date
As of Aug. 6, 2019 • ColCare Mgt Presentation
Columbia Care Inc. (“Columbia Care” or the “Company”) is one of the largest and most experienced multi-state operators in the medical cannabis industry, with licenses in 15 jurisdictions in the US and the EU. With over 1.2 million successful sales transactions since its inception, Columbia Care is a patient-centered organization setting the standard for compassion, professionalism, quality, caring and innovation, working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world. The Company is committed to providing the type of education and transparency patients deserve and quality of product that clinicians expect.
Columbia Care Inc.
745 5th Avenue
New York, NY 10151
Gary F. Santo, Jr.
Vice President, Investor Relations
Odyssey Trust Company
350 – 300 5th Avenue SW
Calgary, AB T2P 3C4